Global MRI Compatible IV Infusion Pumps Market Size By Type (Non-magnetic Pumps, Magnetic Pump System with Shielding), By Application (Hospitals, Ambulatory Surgical Centres), By Region, And Segment F...

The Global MRI Compatible IV Infusion Pumps Market was valued at USD 185 million in 2023 and is projected to reach USD 312 million by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. The market growth is primarily driven by the increasing number of MRI procedures worldwide, the rising need for patient safety during imaging, and technological advancements in infusion pump design that ensure compatibility with high magnetic fields. These specialized infusion pumps allow for uninterrupted drug delivery even during MRI scans, eliminating the risks associated with pausing infusion therapy.

Drivers:

1. Rising Volume of MRI Procedures:

As MRI becomes a standard imaging tool in diagnostic protocols, the demand for MRI-compatible devices, including IV infusion pumps, is rising. These devices enable clinicians to deliver essential medications without removing the patient from the MRI environment.

2. Increasing Need for Patient Safety in Imaging:

Ensuring continuous and accurate medication delivery during MRI scans enhances patient outcomes and reduces complications associated with interrupted infusion therapies, especially in critical care settings.

3. Technological Innovations in Pump Design:

Recent advancements in infusion pump technology have led to the development of compact, shielded, and wireless MRI-compatible pumps that maintain performance under high-field MRI environments, supporting their widespread adoption.

Restraints:

1. High Cost of MRI-Compatible Devices:

The initial cost of acquiring MRI-compatible IV infusion pumps is significantly higher than conventional pumps, which may limit their use in cost-sensitive healthcare settings and developing regions.

2. Limited Awareness and Training:

Despite technological availability, some healthcare providers lack awareness or training in the use of MRI-compatible devices, resulting in underutilization and reliance on alternative solutions.

Opportunity:

1. Expansion of MRI Infrastructure in Emerging Markets:

The installation of new MRI systems in developing regions is driving demand for compatible medical devices, creating growth opportunities for infusion pump manufacturers.

2. Integration with Wireless and Smart Technologies:

Future innovations include the integration of MRI-compatible pumps with smart hospital systems and remote monitoring features, providing added safety and operational efficiency.

Market by System Type Insights:

Based on system type, Syringe Pumps held the largest market share in 2023. These pumps are favored due to their precise drug delivery in MRI settings, especially for pediatric and critical care patients. However, the Volumetric Pumps segment is expected to grow at a faster pace due to rising demand for continuous fluid administration in long-duration MRI procedures.

Market by End-use Insights:

In terms of end-use, Hospitals dominated the market in 2023, accounting for over 60% of global revenue. The need for advanced patient care, integration with MRI departments, and the presence of established imaging infrastructure drive this dominance. The Diagnostic Imaging Centers segment is expected to grow significantly, propelled by increasing outpatient MRI procedures.

Market by Regional Insights:

North America held the largest share of the global MRI compatible IV infusion pumps market in 2023, attributed to its advanced healthcare infrastructure, high MRI utilization rate, and early adoption of safety-enhancing medical devices. Asia-Pacific is anticipated to witness the fastest growth through 2031, driven by expanding diagnostic imaging capabilities and rising healthcare investments in countries like China and India.

Competitive Scenario:

Key players in the MRI compatible IV infusion pumps market include IRadimed Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, Smiths Medical, Becton, Dickinson and Company (BD), and Medtronic plc. These companies are focusing on innovations, regulatory approvals, and regional expansion to gain competitive advantages.

In 2023, IRadimed Corporation launched a next-generation MRI-compatible infusion system with improved battery life and intuitive interface.

In 2024, Fresenius Kabi announced a strategic collaboration to integrate AI-assisted drug monitoring into its MRI-compatible pump systems.

Scope of Work – Global MRI Compatible IV Infusion Pumps Market

Report Metric Details

Market Size (2023) USD 185 million

Projected Market Size (2031) USD 312 million

CAGR (2023–2031) 6.8%

Key Segments by System Type Syringe Pumps, Volumetric Pumps

Key Segments by End-use Hospitals, Diagnostic Imaging Centers

Leading Region North America

Key Players IRadimed, Fresenius Kabi, B. Braun, Smiths Medical, BD

Growth Drivers Rising MRI procedures, patient safety, tech innovation

Opportunities Emerging markets, smart tech integration

Key Market Developments:

March 2023: IRadimed received FDA clearance for its portable MRI-compatible infusion pump featuring real-time monitoring.

August 2024: B. Braun introduced a cloud-integrated MRI infusion system in select European hospitals.

January 2025: Smiths Medical partnered with imaging centers to pilot test its new shielded MRI pump series.

FAQs:

1) What is the cur